Skip to main content

Table 2 The evaluation of the risk of bias in research using the Newcastle–Ottawa scale

From: Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis

Study

Selection (0–4)

Comparability (0–2)

Outcome (0–3)

Total

REC

SNEC

AE

DO

SC

AF

AO

FU

AFU

Hwang, Hye Won et al. [11]

1

0

1

1

1

1

1

1

1

8

Ahn, S. G et al. [12]

1

0

1

1

1

0

1

0

0

5

Yang, Xia et al. [13]

1

0

1

1

1

0

1

1

1

7

Herrero-Vicent, C et al. [14]

0

0

1

1

0

0

1

1

0

4

Luen, S. J et al. [15]

1

0

1

1

1

0

1

1

1

7

Fujimoto, Yukie et al. [16]

1

0

1

1

1

1

0

1

1

7

Adams, S et al. [17]

1

1

1

1

1

1

1

1

1

9

Dieci, M. V et al.2014 [18]

1

0

1

1

1

1

0

1

1

7

Perez, E. A et al. [19]

1

0

1

1

1

1

1

1

1

8

Dieci, M. V et al.2015 [20]

1

0

1

1

1

1

1

1

1

8

Loi, S et al.2013 [5]

1

1

1

1

1

1

1

1

1

9

Loi, S et al.2014 [21]

1

1

1

1

1

1

1

1

1

9

Yasmin Issa-Nummer et al. [22]

1

0

1

1

1

1

1

1

1

8

Denkert, C et al.2010 [4]

1

1

1

1

1

1

1

1

1

9

Denkert, C et al.2015 [23]

1

1

1

1

1

1

1

1

1

9

Pruneri, G et al. [24]

1

0

1

1

1

1

1

1

1

8

Ingold Heppner, B et al. [25]

1

0

1

1

1

1

1

1

1

8

Denkert, C et al.2018 [26]

1

1

1

1

1

1

1

1

1

9

Wang, Qiong et al. [27]

0

0

1

1

1

0

0

1

1

5

Brodsky, Alexander S et al. [28]

0

0

1

1

1

0

0

1

1

5

Leon-Ferre, Roberto A et al. [29]

1

1

1

1

1

1

1

1

1

9

Salgado, Roberto et al. [30]

1

1

1

1

1

1

1

1

1

9

Ignatiadis, Michail et al. [31]

1

0

1

1

1

0

1

0

1

6

Mori, H et al. [32]

1

0

1

1

1

0

1

1

1

7

Dieci, M. V et al.2016 [33]

1

1

1

1

1

1

1

0

0

7

Ruan, Miao et al. [34]

1

0

1

1

1

0

1

0

0

5

O’Loughlin, Mark et al. [35]

1

0

1

1

1

0

1

0

0

5

Ali, H. Raza et al. [36]

1

1

1

1

1

1

1

0

0

7

Song, I. H et al. [37]

1

0

1

1

1

1

1

0

0

6

Li, X et al. [38]

1

0

1

1

1

1

1

0

0

6

Würfel, F et al. [39]

1

0

1

1

1

1

1

0

0

6

Hamy, A. S et al. [40]

1

1

1

1

1

1

1

0

0

7

Khoury, T et al. [41]

1

1

1

1

1

1

1

0

0

7

  1. REC Representativeness of the exposed cohort, SNEC Selection of the non exposed cohort, AE Ascertainment of exposure, DO Demonstration that outcome of interest was not present at start of study, SC study controls for age, sex, AF study controls for any additional factor, AO Assessment of outcome, FU follow-up long enough for outcomes to occur (36 Months), AFU Adequacy of follow up of cohorts (≥90%).“1” means that the study is meeted the item and “0” means the opposite situation